Fetal hyperinsulinemia, characterized by elevated insulin levels, is a critical condition that can result in neonatal and long‐term metabolic complications, such as obesity, type 2 diabetes mellitus (T2DM), and cardiovascular diseases.1 This evidence concerns the gene INS and type 2 diabetes mellitus.